ARlncRNA CDKN2B-AS1 enhances hepatocellular carcinoma invasion, proliferation, and migration by targeting and inhibiting miR-199a-5p to suppress apoptosis and autophagy, which is expected to be a breakthrough for future diagnosis and treatment. This evidence concerns the gene CDKN2B and hepatocellular carcinoma.